XOMA Flies On French Diabetes Deal

Company announces that it will license its XOMA 052 diabetes drug to France’s Laboratoires Servier for $15 million.

http://www.forbes.com/2011/01/04/todays-big-gainers-xoma-pmc-marketnewsvideo.html?feed=rss_markets

About the Author

has written 23518 stories on this site.

Copyright © 2010 corporatecommunicationsnews101.com